
Massive US study finds no autism risk from MMR before age 2
A national retrospective study of more than 2.5 million children found no association between receiving the MMR vaccine before age 2 and an autism diagnosis, with the first dose (11.5–24 months) not linked to higher autism risk. The roundup also reports the Ebola outbreak in the Democratic Republic of the Congo as the second-deadliest on record (3,695 cases, 1,623 deaths; CFR 44%), and Moderna’s phase 3 norovirus vaccine failing to meet early efficacy criteria but continuing in trials.

